Reinhold Kreutz
0000-0002-4818-211X
16 papers found
Refreshing results…
Rationale for the Inclusion of β-Blockers Among Major Antihypertensive Drugs in the 2023 European Society of Hypertension Guidelines
Highlights of the 2023 European Society of Hypertension Guidelines: what has changed in the management of hypertension in patients with cardiac diseases?
Rationale of treatment recommendations in the 2023 ESH hypertension guidelines
Transmembrane protein 14A protects glomerular filtration barrier integrity
What Is the Current Best Drug Treatment for Hypertensive Heart Failure With Preserved Ejection Fraction? Review of the Totality of Evidence
Women’s health, cardiovascular risk and hypertension: the perspective still needs to improve
TIME to face the reality about evening dosing of antihypertensive drugs in hypertension
Harmonization of the American College of Cardiology/American Heart Association and European Society of Cardiology/European Society of Hypertension Blood Pressure/Hypertension Guidelines: Comparisons, Reflections, and Recommendations
Diverse pharmacological properties, trial results, comorbidity prescribing and neural pathophysiology suggest European hypertension guideline downgrading of beta-blockers is not justified
Harmonization of the American College of Cardiology/American Heart Association and European Society of Cardiology/European Society of Hypertension Blood Pressure/Hypertension Guidelines
Single-pill combinations, hypertension control and clinical outcomes: potential, pitfalls and solutions
Thirty years with LIFE—a randomized clinical trial with more than 200 published articles on clinical aspects of left ventricular hypertrophy
Individualized Beta-Blocker Treatment for High Blood Pressure Dictated by Medical Comorbidities: Indications Beyond the 2018 European Society of Cardiology/European Society of Hypertension Guidelines
Methodological Aspects of Meta-Analyses Assessing the Effect of Blood Pressure–Lowering Treatment on Clinical Outcomes
Missing Verification of Source Data in Hypertension Research: The HYGIA PROJECT in Perspective
COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options
Missing publications? Search for publications with a matching author name.